$BCBP
BCB BANCORP INC

2020 Q4 Form 10-K Financial Statement

#000122845421000025 Filed on March 10, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $28.34M $28.47M $27.21M
YoY Change -8.5% -9.24% -11.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $700.0K $800.0K
YoY Change 0.0% 0.0% 14.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $5.584M $7.576M $9.215M
YoY Change -48.72% -28.56% -6.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $10.20M $11.78M $3.847M
YoY Change 39.52% 55.14% -49.01%
Income Tax $2.904M $3.465M $1.121M
% Of Pretax Income 28.47% 29.42% 29.14%
Net Earnings $7.298M $8.312M $2.726M
YoY Change 42.43% 58.87% -47.85%
Net Earnings / Revenue 25.76% 29.2% 10.02%
Basic Earnings Per Share $0.41 $0.47 $0.14
Diluted Earnings Per Share $0.41 $0.47 $0.14
COMMON SHARES
Basic Shares Outstanding 17.08M 17.07M 17.18M
Diluted Shares Outstanding 17.07M 17.18M

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $261.2M $160.6M $412.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $15.27M $15.97M $18.65M
YoY Change -23.33% -21.4% -4.26%
Goodwill $5.200M $5.200M
YoY Change -1.89%
Intangibles
YoY Change
Long-Term Investments $17.72M $14.50M $12.68M
YoY Change 608.68% 147.58% 114.93%
Other Assets $12.60M $12.20M $11.30M
YoY Change 12.5% -8.96% -13.08%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.821B $2.842B $2.987B
YoY Change -2.97% 0.6% 9.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $15.20M $16.00M $13.50M
YoY Change -43.28% 13.48% -8.16%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.20M $16.00M $13.50M
YoY Change -43.28% 13.48% -8.16%
LONG-TERM LIABILITIES
Long-Term Debt $37.00M $37.00M $36.90M
YoY Change 0.54% 0.54% 0.54%
Other Long-Term Liabilities $10.30M $13.70M $10.40M
YoY Change -402.94% 17.09% -9.57%
Total Long-Term Liabilities $47.30M $50.70M $47.30M
YoY Change 41.62% 4.54% -1.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.20M $16.00M $13.50M
Total Long-Term Liabilities $47.30M $50.70M $47.30M
Total Liabilities $2.572B $2.600B $2.746B
YoY Change -3.61% -0.08% 9.09%
SHAREHOLDERS EQUITY
Retained Earnings $58.34M $53.74M $48.10M
YoY Change 20.45% 16.97% 10.96%
Common Stock $192.3M $191.8M $191.2M
YoY Change 1.04% 8.18% 8.14%
Preferred Stock $25.72M $23.48M $27.96M
YoY Change 2.83% -6.14% 11.75%
Treasury Stock (at cost) $26.92M $26.92M $26.92M
YoY Change 22.09% 22.09% 22.09%
Treasury Stock Shares $2.467M $2.467M $2.467M
Shareholders Equity $249.2M $242.7M $241.0M
YoY Change
Total Liabilities & Shareholders Equity $2.821B $2.842B $2.987B
YoY Change -2.97% 0.6% 9.08%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income $7.298M $8.312M $2.726M
YoY Change 42.43% 58.87% -47.85%
Depreciation, Depletion And Amortization $800.0K $700.0K $800.0K
YoY Change 0.0% 0.0% 14.29%
Cash From Operating Activities $132.7M $4.000M -$3.100M
YoY Change 1326.88% -4.76% -173.81%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$1.100M -$100.0K
YoY Change -66.67% -31.25% -80.0%
Acquisitions
YoY Change
Other Investing Activities -$8.100M -$95.50M -$223.2M
YoY Change -109.41% -250.39% -1778.2%
Cash From Investing Activities -$8.200M -$96.60M -$223.3M
YoY Change -109.57% -255.81% -1844.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.90M -159.1M 43.50M
YoY Change -130.37% -292.15% 154.39%
NET CHANGE
Cash From Operating Activities 132.7M 4.000M -3.100M
Cash From Investing Activities -8.200M -96.60M -223.3M
Cash From Financing Activities -23.90M -159.1M 43.50M
Net Change In Cash 100.6M -251.7M -182.9M
YoY Change -42.08% -268.93% -636.36%
FREE CASH FLOW
Cash From Operating Activities $132.7M $4.000M -$3.100M
Capital Expenditures -$100.0K -$1.100M -$100.0K
Free Cash Flow $132.8M $5.100M -$3.000M
YoY Change 1283.33% -12.07% -163.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
CY2020 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
000-50275
CY2020 dei Entity Registrant Name
EntityRegistrantName
BCB BANCORP, INC.
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
CY2020 dei City Area Code
CityAreaCode
800
CY2020 dei Local Phone Number
LocalPhoneNumber
680-6872
CY2020 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Trading Symbol
TradingSymbol
BCBP
CY2020 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
129700000
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17121319
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
23201000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
24985000
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
238028000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
525368000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2020Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2019Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17717000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2500000
CY2020Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
3530000
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
917000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33639000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2295021000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
11324000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
13821000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15272000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19920000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
12924000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
8318000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
414000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12574000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11180000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5488000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5552000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14988000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1915950000
CY2019Q4 us-gaap Other Assets
OtherAssets
9283000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13246000
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
61033000
CY2020Q4 us-gaap Other Assets
OtherAssets
9011000
CY2020Q4 us-gaap Assets
Assets
2821016000
CY2019Q4 us-gaap Assets
Assets
2907468000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
402100000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
271702000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2090361000
CY2020Q4 us-gaap Deposits
Deposits
2318050000
CY2019Q4 us-gaap Deposits
Deposits
2362063000
CY2020Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
191161000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
245800000
CY2020Q4 us-gaap Subordinated Debt
SubordinatedDebt
37042000
CY2019Q4 us-gaap Subordinated Debt
SubordinatedDebt
36810000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15224000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13380000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
10328000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9942000
CY2020Q4 us-gaap Liabilities
Liabilities
2571805000
CY2019Q4 us-gaap Liabilities
Liabilities
2667995000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2596
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2596
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8340
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8340
CY2020Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25723000
CY2019Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25016000
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19574858
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19484046
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17107640
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17516828
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
192276000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
190294000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58335000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48429000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-205000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2218000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2467218
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1967218
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
26918000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
22048000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2821016000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2907468000
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107153000
CY2019 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
113981000
CY2020 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
1748000
CY2019 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
2743000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
1690000
CY2019 us-gaap Interest Income Other
InterestIncomeOther
567000
CY2020 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2835000
CY2019 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
6264000
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
113426000
CY2019 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
123555000
CY2020 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
6147000
CY2019 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
7247000
CY2020 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
440000
CY2019 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
428000
CY2020 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
19360000
CY2019 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
25394000
CY2020 us-gaap Interest Expense Deposits
InterestExpenseDeposits
25947000
CY2019 us-gaap Interest Expense Deposits
InterestExpenseDeposits
33069000
CY2020 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
7069000
CY2019 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
7882000
CY2020 us-gaap Interest Expense
InterestExpense
33016000
CY2019 us-gaap Interest Expense
InterestExpense
40951000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
80410000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
82604000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2069000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
70969000
CY2019 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
80535000
CY2020 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2948000
CY2019 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3359000
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1033000
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
892000
CY2019 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1036000
CY2020 bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
26000
CY2019 bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-38000
CY2019 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
177000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
CY2020 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
964000
CY2019 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
262000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2019 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
201000
CY2020 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
497000
CY2019 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
249000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4299000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3516000
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1548000
CY2019 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1381000
CY2020 bcbp Regulatory Assessments
RegulatoryAssessments
1344000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
21034000
CY2020 us-gaap Noninterest Income
NoninterestIncome
12490000
CY2019 us-gaap Noninterest Income
NoninterestIncome
5391000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
25916000
CY2019 us-gaap Labor And Related Expense
LaborAndRelatedExpense
28456000
CY2020 us-gaap Occupancy Net
OccupancyNet
11748000
CY2019 us-gaap Occupancy Net
OccupancyNet
10660000
CY2020 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3812000
CY2019 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3187000
CY2020 us-gaap Professional Fees
ProfessionalFees
1682000
CY2019 us-gaap Professional Fees
ProfessionalFees
2033000
CY2019 bcbp Regulatory Assessments
RegulatoryAssessments
914000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
127000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
334000
CY2020 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
101000
CY2019 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
71000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1150000
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6608000
CY2019 us-gaap Other Noninterest Expense
OtherNoninterestExpense
8547000
CY2020 us-gaap Noninterest Expense
NoninterestExpense
54036000
CY2019 us-gaap Noninterest Expense
NoninterestExpense
55583000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29423000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30343000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9309000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
21034000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1300000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1346000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19557000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19688000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.20
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17210000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16367000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17226000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16423000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2020 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
964000
CY2019 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
262000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
3335000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
3254000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
826000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
803000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2509000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2451000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
704000
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
-591000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-208000
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
184000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-496000
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
407000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2013000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2858000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22870000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23892000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
200215000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
21034000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2858000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1500
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
987000
CY2019 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1346000
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8714000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
374000
CY2019 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
496224
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2013000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
126000
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
10485000
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1194000
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1300000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9225000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
483000
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4870000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22522000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2069000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2013000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
21034000
CY2020 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2995000
CY2019 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2886000
CY2020 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
2553000
CY2019 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
3038000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1280000
CY2020 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
25917000
CY2019 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
21950000
CY2020 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
24196000
CY2019 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
23222000
CY2020 bcbp Cares Act Proceeds From Sale Of Paycheck Protection Plan Loans
CaresActProceedsFromSaleOfPaycheckProtectionPlanLoans
124549000
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
892000
CY2019 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1036000
CY2020 us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
-293000
CY2020 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
964000
CY2019 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
262000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2019 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
201000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-38000
CY2019 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
177000
CY2020 bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
26000
CY2019 bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1033000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1194000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
987000
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4606000
CY2019 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-60000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-272000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-183000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1245000
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
147000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
927000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-830000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139345000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24267000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
32730000
CY2019 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-21000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2019 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
201000
CY2020 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
40000
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Reclassification</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts as of and for the year ended December 31, 2019 have been reclassified to conform to the current year’s presentation. These changes had no effect on the Company’s consolidated results of operations or financial position.</span></p>
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17700000
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2500000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195264000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12652000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10092000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
34262000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
40804000
CY2019 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
2530000
CY2020 bcbp Number Of Locations
NumberOfLocations
29
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1750000
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
222000
CY2020Q4 bcbp Other Real Estate Owned Number Of Properties
OtherRealEstateOwnedNumberOfProperties
1
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
414000
CY2019Q4 bcbp Other Real Estate Owned Number Of Properties
OtherRealEstateOwnedNumberOfProperties
2
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1600000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
21034000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19557000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Concentration of Risk</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments which potentially subject the Company and its subsidiaries to concentrations of credit risk consist of cash and cash equivalents, investment and mortgage-backed securities and loans.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents include amounts placed with highly rated financial institutions. Securities include securities backed by the U.S. Government and other highly rated instruments. The Bank’s lending activity is primarily concentrated in loans collateralized by real estate in the State of New Jersey and the New York metropolitan area as a result, credit risk related to loans is broadly dependent on the real estate market and general economic conditions in the area.</span>
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9225000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8714000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28861
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17210000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19688000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16367000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.20
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
56000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19557000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17226000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19688000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16423000
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1300000
CY2019 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1346000
CY2020 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
77098000
CY2019 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1153000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
26601000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14996000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7419000
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
60000000
CY2020 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
878000
CY2019 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
2417000
CY2020 bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
1416000
CY2019 bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
402000
CY2020 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
48360000
CY2020 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
200186000
CY2019 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-98849000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1388000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2513000
CY2020 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-2497000
CY2019 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
416000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-315491000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
135104000
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-44013000
CY2019 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
181339000
CY2020 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
88161000
CY2019 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
50000000
CY2020 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
142800000
CY2019 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
50000000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4870000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
357000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19113000
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
11192000
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5310000
CY2020 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
10485000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-112978000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
195718000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-289124000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
355089000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
42000
CY2020Q4 bcbp Acquired Loans Unpaid Principal Balance
AcquiredLoansUnpaidPrincipalBalance
179601000
CY2019Q4 bcbp Acquired Loans Unpaid Principal Balance
AcquiredLoansUnpaidPrincipalBalance
226333000
CY2020Q4 bcbp Acquired Loans Recorded Investment
AcquiredLoansRecordedInvestment
152556000
CY2019Q4 bcbp Acquired Loans Recorded Investment
AcquiredLoansRecordedInvestment
192826000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1681000
CY2018Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
2704000
CY2020 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
603000
CY2019 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
1023000
CY2020Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1078000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1681000
CY2019 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference
0
CY2020 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference
0
CY2019Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
33771000
CY2018Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
34394000
CY2019 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
250000
CY2020 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
4612000
CY2019 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
873000
CY2020Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
29159000
CY2019Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
33771000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
506000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4461000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29178000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
83201000
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2246817000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2330018000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22359000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
743000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
49000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2069000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3264000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
20470000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
26912000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2176403000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1500000
CY2019 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
967000
CY2020 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
710000
CY2019 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
1100000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
333000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2020Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
1100000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
3500000
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
68610000
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
82212000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19647000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29082000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
14591000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
20722000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7265000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
10270000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
83201000
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
102934000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
26912000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
39352000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
31599000
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1266000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
25102000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1064000
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9497000
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
429000
CY2019 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8324000
CY2019 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
334000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
41096000
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1695000
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
33426000
CY2019 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1398000
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
16063000
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
17732000
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
9
CY2020 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
1205000
CY2020 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
1128000
CY2019 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
7
CY2019 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
1930000
CY2019 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
2182000
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
216000
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2019 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
105000
CY2019 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
30879000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4414000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
16962000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2299139000
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2330018000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
333000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
14522000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2188793000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2203315000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35529000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40541000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20257000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20621000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15272000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19920000
CY2020 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2995000
CY2019 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2886000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4254000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3407000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3582000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3176000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2331000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1939000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1520000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
97074000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2822000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
140000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
92266000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
615000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1268000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
11613000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
73000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1278000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
67000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
12891000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
140000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
13073000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
656000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
23212000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
612000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36285000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1268000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2330018000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1358000
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1174000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33639000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
34997000
CY2019Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
24908000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2295021000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
242600000
CY2019Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
274900000
CY2020Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
12924000
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
8318000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
402100000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
271702000
CY2020Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
613882000
CY2019Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
394074000
CY2020Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
315208000
CY2019Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
305790000
CY2020Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1331190000
CY2019Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
971566000
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
297765000
CY2019Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
260545000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
689095000
CY2019Q4 us-gaap Time Deposits
TimeDeposits
1129952000
CY2020Q4 us-gaap Deposits
Deposits
2318050000
CY2019Q4 us-gaap Deposits
Deposits
2362063000
CY2020Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
302900000
CY2019Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
311200000
CY2020Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
35300000
CY2020Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
581315000
CY2020Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
65567000
CY2020Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
23663000
CY2020Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
11757000
CY2020Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
6793000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
689095000
CY2020Q4 us-gaap Deposits Received For Securities Loaned At Carrying Value
DepositsReceivedForSecuritiesLoanedAtCarryingValue
20000000.0
CY2020 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
160000
CY2019 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
57000
CY2020 us-gaap Shortterm Debt Maximum Monthend Outstanding Amount
ShorttermDebtMaximumMonthendOutstandingAmount
25000000
CY2019 us-gaap Shortterm Debt Maximum Monthend Outstanding Amount
ShorttermDebtMaximumMonthendOutstandingAmount
7330000
CY2020Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0036
CY2019Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0241
CY2020Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0166
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
191161000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0216
CY2019Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
245800000
CY2020 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
2600000
CY2019 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
0
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
814600000
CY2019Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
772800000
CY2019Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2020Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2020 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.50
CY2020Q4 bcbp Maximum Total Debt Under Debt Covenant
MaximumTotalDebtUnderDebtCovenant
1412000000
CY2020 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.50
CY2020Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
-3069000
CY2019Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
-2365000
CY2020 bcbp Estimated Long Term Inflation Rate
EstimatedLongTermInflationRate
0.03
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
0
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
521000
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
513000
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
505000
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
489000
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
491000
CY2020Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
2354000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
391000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
884000
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
558000
CY2019 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
466000
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
636000
CY2019 us-gaap Restricted Stock Expense
RestrictedStockExpense
521000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1194000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
987000
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRangeUpperRangeLimit
12.46
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.68
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81278
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.96
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
56642
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
11.77
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2332
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
11.97
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
22304
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.46
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1104600
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.36
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
194000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
CY2019 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRangeLowerRangeLimit
10.55
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.55
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1500
CY2019 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeLowerRangeLimit
10.55
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRange
10.55
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1192348
CY2020 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.55
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
98875
CY2019 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
12.46
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.46
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1200975
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y18D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2806000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8127
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRangeLowerRangeLimit
11.26
CY2020 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y14D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
333000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
817536
CY2020Q4 bcbp Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Underlying Unexercised Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnderlyingUnexercisedOptions
374812
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
805000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5Y29D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y5M26D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0197
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.223
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0449
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.54
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
685000
CY2020Q4 bcbp Deferred Income Tax Assets Valuation Adjustment On Loans Receivable Acquired
DeferredIncomeTaxAssetsValuationAdjustmentOnLoansReceivableAcquired
1810000
CY2019Q4 bcbp Deferred Income Tax Assets Valuation Adjustment On Loans Receivable Acquired
DeferredIncomeTaxAssetsValuationAdjustmentOnLoansReceivableAcquired
2379000
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16881000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
145000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
479000
CY2020Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
4284000
CY2019Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3841000
CY2020Q4 bcbp Minimum Percentage Of Capital Stock Surplus Under Dividend Restriction
MinimumPercentageOfCapitalStockSurplusUnderDividendRestriction
0.50
CY2020 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
18212000
CY2019 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
12033000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6407000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4761000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4172000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3268000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10579000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8029000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1122000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
935000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-891000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
345000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2013000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1280000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9309000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
8884000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
6374000
CY2020Q4 bcbp Deferred Income Tax Assets Other Real Estate Owned Expenses
DeferredIncomeTaxAssetsOtherRealEstateOwnedExpenses
9000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
755000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
762000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
181000
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1088000
CY2020Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
688000
CY2019Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
162000
CY2020Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1455000
CY2019Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1551000
CY2020Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
4352000
CY2019Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3880000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
997000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
697000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19327000
CY2019Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
805000
CY2020Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
548000
CY2019Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
576000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6753000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5701000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12574000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11180000
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8700000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6900000
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7400000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6179000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6372000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2592000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2854000
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
99000
CY2019 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
102000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
110000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
203000
CY2020 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
217000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-18000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2020Q1 us-gaap Interest Expense
InterestExpense
10641000
CY2020Q2 us-gaap Interest Expense
InterestExpense
9215000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9309000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.291
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
CY2020Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
253516000
CY2019Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
198960000
CY2020 bcbp Number Of Operating Leases
NumberOfOperatingLeases
28
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3509000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
824000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14988000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2992000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12232000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15224000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M25D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0267
CY2020Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4927000
CY2020Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3165000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4140000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15224000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2992000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17717000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
117473000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2500000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
94113000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
14591000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7265000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-205000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2218000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
29419000
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27206000
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28466000
CY2020Q4 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28335000
CY2020Q3 us-gaap Interest Expense
InterestExpense
7576000
CY2020Q4 us-gaap Interest Expense
InterestExpense
5584000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18778000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17991000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20890000
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
22751000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1500000
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3300000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2726000
CY2020Q4 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1915000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
17278000
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14691000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
18164000
CY2020Q4 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20836000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
683000
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
1108000
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
6955000
CY2020Q4 us-gaap Noninterest Income
NoninterestIncome
3744000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
14364000
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
11952000
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
13342000
CY2020Q4 us-gaap Noninterest Expense
NoninterestExpense
14378000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3597000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3847000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11777000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10202000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1076000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1121000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3465000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2904000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2521000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2726000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8312000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7298000
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
CY2020Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
341000
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
332000
CY2020Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
285000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2179000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2385000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7980000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7013000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30478000
CY2019Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30742000
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
31365000
CY2019Q4 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30966000
CY2019Q1 us-gaap Interest Expense
InterestExpense
9576000
CY2019Q2 us-gaap Interest Expense
InterestExpense
9877000
CY2019Q3 us-gaap Interest Expense
InterestExpense
10605000
CY2019Q4 us-gaap Interest Expense
InterestExpense
10889000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20902000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20865000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20760000
CY2019Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20077000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
889000
CY2019Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
755000
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
900000
CY2019Q4 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-475000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20013000
CY2019Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20110000
CY2019Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
19860000
CY2019Q4 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20552000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
1660000
CY2019Q2 us-gaap Noninterest Income
NoninterestIncome
1328000
CY2019Q3 us-gaap Noninterest Income
NoninterestIncome
1383000
CY2019Q4 us-gaap Noninterest Income
NoninterestIncome
1020000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
13777000
CY2019Q2 us-gaap Noninterest Expense
NoninterestExpense
13894000
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
13652000
CY2019Q4 us-gaap Noninterest Expense
NoninterestExpense
14260000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7896000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7544000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7591000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7312000
CY2019Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
317000
CY2019Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
CY2019Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2445000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2317000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2359000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2188000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
5451000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
5227000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5232000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
5124000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5134000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4885000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4890000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4782000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14

Files In Submission

Name View Source Status
0001228454-21-000025-index-headers.html Edgar Link pending
0001228454-21-000025-index.html Edgar Link pending
0001228454-21-000025.txt Edgar Link pending
0001228454-21-000025-xbrl.zip Edgar Link pending
bcbp-20201231.xsd Edgar Link pending
bcbp-20201231x10k.htm Edgar Link pending
bcbp-20201231x10kg001.jpg Edgar Link pending
bcbp-20201231x10k_htm.xml Edgar Link completed
bcbp-20201231xex21.htm Edgar Link pending
bcbp-20201231xex23.htm Edgar Link pending
bcbp-20201231xex31_1.htm Edgar Link pending
bcbp-20201231xex31_2.htm Edgar Link pending
bcbp-20201231xex32.htm Edgar Link pending
bcbp-20201231xex3_1.htm Edgar Link pending
bcbp-20201231_cal.xml Edgar Link unprocessable
bcbp-20201231_def.xml Edgar Link unprocessable
bcbp-20201231_lab.xml Edgar Link unprocessable
bcbp-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending